What are the recommended antibiotic names and dosages for treating a child with cough and an adult with chronic bronchitis?

Antibiotic Recommendations for Chronic Wet Cough

For Children with Chronic Wet Cough

For children ≤14 years with chronic wet cough (>4 weeks duration), prescribe amoxicillin-clavulanate for 2 weeks as first-line therapy 1.

Specific Dosing and Duration

• First-line antibiotic: Amoxicillin-clavulanate (most commonly used in seven prospective studies) 1
• Initial duration: 2 weeks 1
• Target pathogens: Haemophilus influenzae (nontypeable), Moraxella catarrhalis, and Streptococcus pneumoniae 1

Treatment Algorithm

Step 1 - Initial 2-week course:

• If cough resolves → Diagnosis is Protracted Bacterial Bronchitis (PBB) 1
• If cough persists → Proceed to Step 2

Step 2 - Extended treatment (if cough persists after 2 weeks):

• Add an additional 2 weeks of the same antibiotic (total 4 weeks) 1
• If cough resolves → Diagnosis confirmed as PBB
• If cough persists after 4 weeks total → Proceed to Step 3

Step 3 - Further investigation (if cough persists after 4 weeks):

• Perform flexible bronchoscopy with quantitative cultures and/or chest CT 1
• Children with persistent wet cough after 4 weeks of antibiotics have 5.9-fold increased odds of bronchiectasis 1

Alternative Antibiotics

If amoxicillin-clavulanate is contraindicated:

• Clarithromycin (used in three studies) 1
• Erythromycin (used in one study) 1
• Cefaclor (used in one study) 1

Critical Pitfalls

The 2017 CHEST guidelines explicitly advocate for shorter initial courses (2 weeks) rather than 4-6 weeks in the current era of antimicrobial stewardship 1. The British Thoracic Society's recommendation of 4-6 weeks upfront lacks prospective study evidence 1. Starting with 2 weeks allows assessment of response while minimizing unnecessary antibiotic exposure.

---

For Adults with Chronic Bronchitis

For adults with stable chronic bronchitis and chronic cough, there is insufficient evidence to recommend routine antibiotic use for cough relief 2.

Key Distinction

The 2020 CHEST expert panel makes clear that antibiotics, bronchodilators, and mucolytics should NOT be routinely used for chronic cough due to stable chronic bronchitis until proven safe and effective for cough relief specifically 2.

When Antibiotics ARE Indicated in Adults

Antibiotics are appropriate for acute exacerbations of chronic bronchitis (AECB), not stable disease. Use antibiotics when patients have:

Required criteria (must have both):

1. At least 1 key symptom: Increased dyspnea, increased sputum production, OR increased sputum purulence 3
2. At least 1 risk factor: Age ≥65 years, FEV1 <50% predicted, ≥4 exacerbations in 12 months, OR comorbidities 3

Antibiotic Selection for AECB

Moderate severity exacerbation:

• Newer macrolide, extended-spectrum cephalosporin, or doxycycline 3

Severe exacerbation:

• High-dose amoxicillin/clavulanate OR respiratory fluoroquinolone (gatifloxacin, gemifloxacin, or levofloxacin) 4, 3

Target pathogens: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 3

Duration for AECB

Evidence supports 7-14 day courses for acute exacerbations 5. Amoxicillin 1000 mg twice daily is as effective as 750 mg three times daily with similar cure rates (92%) 5.

Critical Distinction

The evidence clearly separates stable chronic bronchitis (where routine antibiotics are NOT recommended) from acute exacerbations (where antibiotics are indicated with specific criteria). The 2020 guidelines emphasize that smoking cessation and removal of environmental irritants are the primary interventions for stable disease 2.